IL122739A0 - Galanthamine derivatives their preparation and pharmaceutical compositions containing them - Google Patents

Galanthamine derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
IL122739A0
IL122739A0 IL12273996A IL12273996A IL122739A0 IL 122739 A0 IL122739 A0 IL 122739A0 IL 12273996 A IL12273996 A IL 12273996A IL 12273996 A IL12273996 A IL 12273996A IL 122739 A0 IL122739 A0 IL 122739A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
pct
preparation
derivatives
Prior art date
Application number
IL12273996A
Other languages
English (en)
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of IL122739A0 publication Critical patent/IL122739A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL12273996A 1995-07-19 1996-07-19 Galanthamine derivatives their preparation and pharmaceutical compositions containing them IL122739A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9514821.9A GB9514821D0 (en) 1995-07-19 1995-07-19 Galanthamine derivatives
PCT/FR1996/001139 WO1997003987A1 (fr) 1995-07-19 1996-07-19 Nouveaux derives de la galanthamine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant

Publications (1)

Publication Number Publication Date
IL122739A0 true IL122739A0 (en) 1998-08-16

Family

ID=10777948

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12273996A IL122739A0 (en) 1995-07-19 1996-07-19 Galanthamine derivatives their preparation and pharmaceutical compositions containing them

Country Status (16)

Country Link
US (1) US5958903A (de)
EP (1) EP0839149B9 (de)
JP (1) JP4177894B2 (de)
AT (1) ATE264332T1 (de)
AU (1) AU6662396A (de)
CA (1) CA2227235C (de)
DE (1) DE69632194T2 (de)
DK (1) DK0839149T3 (de)
ES (1) ES2218596T3 (de)
GB (1) GB9514821D0 (de)
IL (1) IL122739A0 (de)
MX (1) MX9800407A (de)
NO (1) NO980215D0 (de)
PT (1) PT839149E (de)
WO (1) WO1997003987A1 (de)
ZA (1) ZA966163B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100648869B1 (ko) * 1998-09-30 2007-02-28 다케다 야쿠힌 고교 가부시키가이샤 방광 배출력 개선제
US7939522B1 (en) 1998-11-23 2011-05-10 Bonnie M Davis Dosage formulations for acetylcholinesterase inhibitors
OA11740A (en) 1998-12-24 2005-05-13 Janssen Pharmaceutica Nv Controlled release galantamine composition.
US8603546B2 (en) * 1999-01-11 2013-12-10 Herbaceuticals Inc. Herbal supplement for increased muscle strength and endurance for athletes
WO2000041540A2 (en) * 1999-01-11 2000-07-20 Atanas Russinov Djananov Herbal supplement for increased muscle strength and endurance for athletes
PT1086706E (pt) * 1999-03-31 2004-02-27 Eisai Co Ltd Composicao estabilizada que compreende um medicamento nootropico
AU785385B2 (en) * 2000-03-31 2007-03-29 Sanochemia Pharmazeutika Aktiengesellschaft Novel derivatives and analogues of galanthamin
DE10129265A1 (de) * 2001-06-18 2003-01-02 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie
JP4721386B2 (ja) * 2001-07-10 2011-07-13 第一三共株式会社 新規ガランタミン類縁体
DE10134038A1 (de) * 2001-07-12 2003-02-06 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit
EP1681291A1 (de) * 2002-03-25 2006-07-19 Sanochemia Pharmazeutika Aktiengesellschaft Verfahren zur Herstellung von Norgalanthamin, Ihren Isomeren, Salzen und Hydraten
EP1667769A2 (de) * 2003-09-29 2006-06-14 Sanochemia Pharmazeutica Aktiengesellschaft Verwendung von galanthamin und seinen derivaten zum herstellen von arzneimitteln
AT414125B (de) * 2003-09-29 2006-09-15 Sanochemia Pharmazeutika Ag Neue derivate des 4a,5,9,10,11,12-hexahydro- benzofuro(3a,3,2)(2) benzazepin, verfahren zu deren herstellung sowie deren verwendung zur herstellung von arzneimitteln
CA2552114A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Solid dosage formulations of galantamine
CA2551946A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Immediate, controlled and sustained release formulations of galantamine
WO2006124585A2 (en) * 2005-05-13 2006-11-23 Alza Corporation Multilayer drug system for the delivery of galantamine
WO2007035941A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal galantamine delivery system
CN102149398B (zh) * 2008-09-11 2013-12-04 I·B·R·以色列生物科技研究有限公司 雪片莲属鳞茎提取物及其用途
US20120129838A1 (en) * 2009-04-24 2012-05-24 The Industry & Academic Cooperation In Chungnam National University Composition for Preventing and Treating Alopecia Disorder Containing Morgalanthamine Compounds as an Active Ingredient

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663318A (en) * 1986-01-15 1987-05-05 Bonnie Davis Method of treating Alzheimer's disease
US4735169A (en) * 1986-09-03 1988-04-05 Nordson Corporation Adhesive applicator assembly
DE3856594D1 (de) * 1987-05-04 2008-11-27 Bonnie Davis Mittel zur behandlung der alzheimer-krankheit
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
US6323195B1 (en) * 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
US5428159A (en) * 1994-04-08 1995-06-27 Ciba-Geigy Corporation Method of manufacture of (-)-galanthamine in high yield and purity substantially free of epigalanthamine

Also Published As

Publication number Publication date
AU6662396A (en) 1997-02-18
NO980215L (no) 1998-01-16
JP4177894B2 (ja) 2008-11-05
EP0839149A1 (de) 1998-05-06
DK0839149T3 (da) 2004-08-09
CA2227235C (fr) 2010-08-31
WO1997003987A1 (fr) 1997-02-06
ZA966163B (en) 1997-02-10
DE69632194D1 (de) 2004-05-19
JPH11509541A (ja) 1999-08-24
EP0839149B9 (de) 2005-03-09
MX9800407A (es) 1998-04-30
PT839149E (pt) 2004-08-31
NO980215D0 (no) 1998-01-16
DE69632194T2 (de) 2005-03-17
ES2218596T3 (es) 2004-11-16
EP0839149B1 (de) 2004-04-14
US5958903A (en) 1999-09-28
ATE264332T1 (de) 2004-04-15
GB9514821D0 (en) 1995-09-20
CA2227235A1 (fr) 1997-02-06

Similar Documents

Publication Publication Date Title
IL122739A0 (en) Galanthamine derivatives their preparation and pharmaceutical compositions containing them
AU4666996A (en) Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present
ZA973647B (en) Inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them.
MX9700223A (es) Composicion farmaceutica para la liberacion controlada de moguisteina en una suspension liquida.
IL117598A (en) Quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0100731A3 (en) New oxazolidine-, thiazolidine-, pyrrolidine-and piperidin derivatives process for their preparation and pharmaceutical compositions containing them
HUP9900056A2 (hu) Szubsztituált 4-fenil-amino-tiazol-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények
PL314188A1 (en) Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
HUT70544A (en) Heteroaryl-amines as acetyl-cholinesterase inhibitors, pharmaceutical compositions comprising them and process for their preparation
IL119466A (en) Thrombin inhibitors, their preparation and pharmaceutical compositions containing them
AU6617596A (en) Cyclo-oxygenase inhibitor and amidine derivative salts, their preparation process, their use as medicaments, and pharmaceutical compositions containing them
PL319784A1 (en) Keratinocytic growth factor analoques
HUP9702400A3 (en) Substituted camptothecin derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9602635A3 (en) 4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9601062A2 (en) Chromone derivatives, pharmaceutical compositions containing them and process for their preparation
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
HUP0202988A3 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one derivatives and their use as lipase inhibitors, process for their preparation and pharmaceutical compositions containing them
AU2620995A (en) Oxathiolanes, method for their preparation and pharmaceutical compositions containing same
HUP9600173A2 (en) 4-amino-benzoyl-guanidine derivatives, process for preparing them and pharmaceutical compositions containing them
IL106290A0 (en) Enzyme inhibitors,their preparation and pharmaceutical compositions containing them
HUP0001183A3 (en) Pyrrolothiazine and pyrrolothiazepine derivatives, process for their preparation and pharmaceutical compositions containing them
AU685006B2 (en) Metallocenic diarylethylene derivatives, methods for their preparation and pharmaceutical compositions containing same
HUP9700444A3 (en) Diaryl-alkane derivatives containing pyrrolidine group, pharmaceutical compositions containing them and process their preparation
AU2449095A (en) Novel benzylamine derivatives, method for their preparation and pharmaceutical compositions containing same
HUP0001432A3 (en) Pyrroloazepine derivatives, process for their preparation and pharmaceutical compositions containing them